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Association of particles of lipoprotein
subclasses with arterial stiffness in a high-
risk working population: the Baptist
Employee Healthy Heart Study (BEHHS)
Muhammad Aziz1,2,3, Swetha Gannarapu2, Choudhry Humayun2, Usman Siddiqui2, Khurram Nasir2,4,5 and
Ehimen C. Aneni2,6*
Abstract
Background: Arterial stiffness is an independent predictor of cardiovascular disease (CVD) morbidity and mortality.
A risk factor-independent association of arterial stiffness with traditional lipids has been described extensively, but it
is still unclear whether an independent relationship exists between arterial stiffness and particles of lipoprotein
subclasses.
Methods: The Baptist Employee Healthy Heart Study (BEHHS) is a lifestyle intervention study examining the effects
of web-based programs on reducing CVD risk in high-risk persons. Participants had their brachial arterial
augmentation index (AI, a measure arterial stiffness) assessed using the EndoPAT 2000 device. Cardio IQ™ ion
mobility lipoprotein fractionation was utilized for measurement of particles of lipoprotein subclasses.
Results: The population consisted of 182 participants, (74% women, 49% Hispanic) with a mean age of 52 ± 9
years. There was a significant trend association between quartiles of AI and total cholesterol, HDL-c, large LDL-p,
small IDL-p, large IDL-p, and all subclasses of HDL particles (total HDL-p, small HDL-p, and large HDL-p). In logistic
regression analysis, only HDL-c, total LDL-p, large LDL-p, small IDL-p, large IDL-p, total HDL-p, small HDL-p, and
large HDL-p demonstrated significant independent association with AI.
Conclusion: Several lipoprotein subclasses demonstrate independent significant associations with arterial stiffness.
A safe and relatively inexpensive blood test may be useful in identifying subclinical atherosclerosis process in a
relatively young high CVD risk population.
Trial registration: ClinicalTrials.gov, NCT01912209. Registered July 31, 2013
Keywords: Lipoprotein, Lipoprotein subclasses, Arterial stiffness, Augmentation index, Employee population
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
* Correspondence: ehianeni@outlook.com
2Center for Healthcare Advancement & Outcomes, Baptist Health South
Florida, 9555 SW 162nd Ave. MAB, Suite 103, Miami, FL 33196, USA
6Internal Medicine, Section of Cardiovascular Medicine, Yale-New Haven
Hospital, New Haven, CT 06510, USA
Full list of author information is available at the end of the article
The Egyptian Heart
Journal
Aziz et al. The Egyptian Heart Journal           (2020) 72:12 
https://doi.org/10.1186/s43044-020-00046-4
Research highlights
 Cardio IQ™ ion mobility lipoprotein fractionation is
a better estimate of particles of lipid subclasses as
compared to traditional lipid measurement.
 This study is a step toward determining the true
relationship between advanced lipid panel (particles
of lipoprotein subclasses) and augmentation index, a
measure of arterial stiffness.
 Several lipoprotein subclasses demonstrated
independent significant associations with arterial
stiffness.
Background
Arterial stiffness, an age-related irreversible hardening of
vessels, is associated with CVD-related morbidity and
mortality [1–4]. Arterial stiffness can be measured by
augmentation index (AI) and pulse wave velocity (PWV)
that represent as measure of wave reflection and arterial
stiffness [5, 6]. AI increases with age and is closely asso-
ciated with CVD risk factors such as hypertension and
coronary artery disease [7, 8]. It also reflects properties
of cardiac performance and overall ventricular-vascular
coupling [4, 9, 10]. Brachial artery AI is a measure of
both central and peripheral arterial stiffness [6, 11].
The association of arterial stiffness with traditional
lipids, such as total cholesterol (TC), triglycerides (TG),
low-density lipoprotein cholesterol (LDL-c), and high-
density lipoprotein cholesterol (HDL-c), has been de-
scribed in cross-sectional studies among high-risk popula-
tion [12, 13]. However, the relationship between arterial
stiffness and particles of lipoprotein subclasses has been
rarely studied. The aim of this study is to determine the
relationship between traditional lipids and lipoprotein
subclasses (measured by the ion mobility technique) with
brachial artery AI, a measure of arterial stiffness, in a rela-
tively young high-risk employee population.
Methods
The Baptist Employee Healthy Heart Study (BEHHS) is
a randomized controlled trial examining the efficacy of
an interactive internet-delivered program on reducing
metabolic risk in an employee population with diabetes
and/or metabolic syndrome (MS). The design and selec-
tion criteria for BEHHS have been described in detail
previously [14]. The results of this analysis are based on
the data from baseline visit of the study. The study
protocol was approved by the Baptist Health South Flor-
ida Institutional Review Board (IRB#13-028). All partici-
pants have provided written consent to participate in the
study.
The study measured lipoproteins using the ion mobility
technique, a gas chromatography technique that was
adapted to measuring subclasses of lipoproteins and has
been validated in several studies [15, 16]. Details of the
technique have also been previously described [17]. Aug-
mentation index as derived from peripheral arterial to-
nometry (endoPAT Itamar Medical Ltd., Israel) is
calculated from reflected pulse wave indices. It has shown
good test-retest reliability in subjects with metabolic syn-
drome in previous studies [18]. Because the AI is
dependent on the heart rate, it is normalized to a heart
rate of 75. The values provided are gender matched [19].
All statistical analyses were performed using STATA ver-
sion 13 statistical analysis package (StataCorp LP, College
Station, TX) [20]. Continuous variables were expressed as
means ± SD or median (interquartile range). Categorical
variables were represented by frequency and percentage.
Spearman Rank correlation coefficients were calculated for
each class of lipids with AI (continuous variable). The logis-
tic regression model (controlling for age and BMI) was used
to compute the odds ratios and 95% confidence interval
(CI), for an increase in AI with each standard deviation in-
crease in lipoprotein particle.
Results
The mean age of the 182 study participants was 52 ± 9
years with 74% women (n = 134) and 49% Hispanic popu-
lation. Across increasing quartiles of AI, there was a sig-
nificant trend with increasing age and a greater
proportion of females. By contrast, BMIs decreased with
higher AI (Table 1). HDL-c was the only traditional lipid
correlated with AI. Among the lipoprotein subclasses,
Spearman correlation showed that small IDL-p, total
HDL-p, small HDL-p, and large HDL-p were significantly
associated with AI (Table 2). Total cholesterol, large LDL-
p, and large IDL-p were also significantly correlated with
AI. Logistic regression analysis showed that increases in
total LDL-p, large LDL-p, small IDL-p, large IDL-p, total
HDL-p, small HDL-p, and large HDL-p were significantly
associated with increase in AI in the fully adjusted model.
Discussion
Our study findings, that associate higher LDL particles
(total and large) with AI, differ slightly from earlier stud-
ies which showed a significant positive association of
baPWV (a measure of arterial stiffness) with lipoprotein
subclasses of total LDL-p and small LDL-p in relatively
healthy population (age 40–49 years) [21] and with very
small LDL-p in patients with impaired glucose metabol-
ism [22]. The reason for these varied results among
these studies could be due to use of different methods to
examine the peripheral arterial stiffness and use of dif-
ferent laboratory techniques to measure the subclasses
of lipoproteins.
HDL particles do not follow traditional inverse rela-
tionship with CV risk factors, therefore complicating
proper assessment of the relative roles of distinct HDL
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Table 1 Descriptive characteristics of the study population along the quartiles of augmentation index (Al).
Variables [mean (SD) or %] All (n = 182) Q1 Q2 Q3 Q4 P trend
Age in years (SD) 51 (10) 46.26 (9.6) 49.42 (9.18) 52.97 (9.96) 55.91 (7.83) < 0.0001
% female 74 41.30 77.78 82.22 93.33 < 0.0001
Race
White 77.1 68.89 93.18 78.57 68.18 0.503
African American 16.6 26.67 4.55 11.90 22.73
Other 6.3 4.44 2.27 7.14 9.09
BMI [kg/m2] (SD) 34.2 (6) 37.20 (6.3) 35.20 (5.7) 33.11 (5.3) 31.26 (5.1) < 0.0001
SBP [mmHg] (SD) 134 (15.2) 132.52 (12.1) 133.38 (13.6) 134.64 (16.5) 137.09 (17.5) 0.343
DBP [mmHg] (SD) 83 (9.2) 84.06 (8.5) 82.53 (8.5) 82.36 (9.6) 82.02 (10.2) 0.288
Heart rate [HR] 73 (11) 72.39 (11.0) 74.58 (9.1) 74.38 (12.7) 70.76 (11.3) 0.278
Glucose [mg/dL] 105 (37.3) 99.20 (27.5) 106.53 (46.5) 114 (45.7) 100.17 (23.5) 0.325
CRP [mg/L] 6 (7.8) 7.24 (12.8) 5.81 (5.7) 6.26 (6.1) 4.08 (3.0) 0.355
% diabetes mellitus 29 21.74 37.78 31.11 24.44 0.950
% lifetime smoker 34 26.67 31.11 44.19 35.56 0.215
Physical activity [min/ day] 1.68 (0.5) 1.62 (0.5) 1.67 (0.5) 1.68 (0.5) 1.73 (0.5) 0.303
Values are expressed as means ± S.D. or percentages. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, Hs-CRP high-sensitivity
C-reactive protein
Table 2 Association of lipoprotein (LP) subclasses with augmentation index (Al) quartiles in study population (expressed as IQR)
AI continuous AI in ascending quartiles
Spearman
correlation
OR per SD increase in lipid/lipoprotein
Unadjusted Adjusted
TC [mg/dL] 0.1639* 1.30 (0.99–1.71) 1.21 (0.91–1.60)
TG-c [mg/dL] 0.0000 .99 (0.77–1.27) 0.97 (0.74–1.26)
HDL-c [mg/dL] 0.2298** 1.56 (1.19–2.04) 1.19 (0.89–1.60)
LDL-c [mg/dL] 0.0524 1.07 (0.82–1.40) 1.11 (0.84–1.46)
Non-HDL-c [mg/dL] 0.0755 1.18 (0.91–1.54) 1.23 (0.93–1.61)
Total LDL-p [nmol/L] 0.1093 1.31 (1.0–1.73) 1.42 (1.07–1.89)
Very Small LDL-p [nmol/L] 0.0150 1.18 (0.90–1.54) 1.27 (0.97–1.67)
Small LDL-p [nmol/L] 0.0133 1.12 (0.86–1.47) 1.26 (0.95–1.66)
Medium LDL-p [nmol/L] 0.0605 1.23 (0.93–1.61) 1.37 (1.03–1.82)
Large LDL-p [nmol/L] 0.1837* 1.44 (1.10–1.89) 1.40 (1.05–1.86)
Small IDL-p [nmol/L] 0.2643** 1.50 (1.13–1.98) 1.40 (1.05–1.87)
Large IDL-p [nmol/L] 0.1707* 1.41 (1.05–1.88) 1.49 (1.11–2.00)
Total HDL-p [nmol/L] 0.2747** 1.48 (1.10–1.99) 1.41 (1.03–1.94)
Small HDL-p [nmol/L] 0.2507** 1.45 (1.09–1.93) 1.40 (1.03–1.90)
Large HDL-p [nmol/L] 0.2658** 1.48 (1.10–2.00) 1.37 (1.00–1.89)
Small VLDL-p [nmol/L] 0.1203 1.32 (0.99–1.77) 1.43 (1.06–1.94)
Medium VLDL-p [nmol/L] 0.0451 1.19 (0.90–1.57) 1.30 (0.97–1.74)
Large VLDL-p [nmol/L] − 0.0052 1.13 (0.85–1.50) 1.16 (0.87–1.55)
Adjusted for age and BMI. Spearman ρ = Spearman rank correlation coefficient using Bonferroni significance level. Cut-off p value of p < 0.05 was used for
determining significance. Logistic regression models using 95% CI describe the change in AI per SD change in standardized values of lipoproteins. AI
augmentation index, LP lipoprotein, p particle number, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, IDL intermediate-density lipoprotein, HDL
high-density lipoprotein, VLDL very low-density lipoprotein
*p value ≤ 0.05
**p value ≤ 0.005
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particles in cardio-protection [15, 23, 24]. We discovered
that all subclasses of HDL showed a significant positive
association with AI in adjusted models. This finding was
not unique to our study as previous published papers
describe a positive relationship of HDL particles with AI
[21, 25, 26].
Neither triglycerides nor the triglyceride-rich VLDL
particles were associated with the AI in our study popu-
lation. The reasons for this unexpected lack of relation-
ship are not readily clear. Previous studies had shown
strong associations of VLDL particles with peripheral ar-
terial stiffness [21]. Our study showed a paradoxical
trend toward decreasing BMI with increasing AI. Our
study is not the first to report this negative association
of obesity with augmentation index [27]. For this reason,
we controlled for BMI in the lipoprotein statistical
analyses.
Our study is limited by the small sample size which di-
minishes the study’s power. The cross-sectional nature of
the study precludes conclusions on causality. The largely
Hispanic population also limits the generalizability of the
study’s findings. We only measured the association of
lipids with measures of peripheral arterial stiffness. The
inherent variability of the AI as a measure of overall vas-
cular function may indicate that comparison of different
methods of AI is needed to predict the association with all
classes of lipids.
Conclusions
In conclusion, our study shows that measures of lipopro-
tein subclasses are associated with increased peripheral
arterial stiffness as measured by AI in a high metabolic
risk population. Our study represents a step toward de-
termining the true relationship between lipids and arter-
ial stiffness. Once this relationship is clarified further,
pharmacological and lifestyle interventions can be stud-
ied in the context of their effect on levels of these lipo-
protein subclasses, with the aim of correcting these
abnormalities in time and potentially preventing further
CVD events.
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